-+ 0.00%
-+ 0.00%
-+ 0.00%

Market News: US Food and Drug Administration reviewers raised concerns about the Replimune cancer drug trial before the July 30 Advisory Committee meeting.

智通財經·07/28/2026 11:49:14
語音播報
Market News: US Food and Drug Administration reviewers raised concerns about the Replimune cancer drug trial before the July 30 Advisory Committee meeting.